We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Life History of Organoid Nevi Special Reference to Nevus Sebaceus of Jadassohn

Arch Dermatol. 1965;91(6):574-588. doi:10.1001/archderm.1965.01600120006002.
Text Size: A A A
Published online


A review and analysis of 150 cases of organoid nevus is offered. Most of the nevi are situated on the scalp and correspond to the type called nevus sebaceus of Jadassohn. A short historical review of Jadassohn's original work is used to clarify the definition of "nevus." By old usage this term is applied to lesions containing nevus cells. Jadassohn's definition of organoid nevi includes stable localized malformation of the skin through excess or deficiency of one or more of the normal mature constituents, such as hair, glands, epidermis, or connective tissue, and it excludes adenomas and other less mature tumors. Analysis of our 150 cases shows that the so-called nevus sebaceus also usually involves other skin constituents, and sometimes most of them. Its life history includes three stages. An early stage in infancy and childhood often is characterized by underdevelopment of hairs and sebaceous glands. A second phase usually begins at puberty and leads to massive development of sebaceous glands, papillomatous epidermal hyperplasia, and maturation of apocrine glands, which are present in a considerable number of cases. The third stage is due to the complicating development of benign and malignant nevoid tumors in the original nevus. Among the 52 tumors found in our series, basal cell epitheliomas and hidradenomas of various types were in the majority. The practical consequence of this analysis for prognostication and treatment of organoid nevi are outlined.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.